✦ LIBER ✦

A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer

✍ Scribed by Defferrari Carlotta, Campora Sara, D’Amico Mauro, Piccardo Arnoldo, Biscaldi Ennio, Rosselli Daniela, Pasa Ambra, Puntoni Matteo, Gozza Alberto, Gennari Alessandra, Zanardi Silvia, Lionetto Rita, Bandelloni Michela, DeCensi Andrea

Book ID: 119913812
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 581 KB
Volume: 5
Category: Article
ISSN: 1757-2215
DOI: 10.1186/1757-2215-5-17

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Striking response with bevacizumab and c

Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation

✍ K. Prassl; A. Sahanic; B. Reicher; H. Denz; M. Freund; M. Fiegl 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 191 KB

Efficacy and safety of low-dose metronom

Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer

✍ P. Fedele; A. Marino; L. Orlando; P. Schiavone; A. Nacci; F. Sponziello; P. Rizz 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Feasibility of Surgery After Systemic Tr

Feasibility of Surgery After Systemic Treatment with the Humanized Recombinant Antibody Bevacizumab in Heavily Pretreated Patients with Advanced Epithelial Ovarian Cancer

✍ Jalid Sehouli; G. Papanikolaou; E.-I. Braicu; K. Pietzner; P. Neuhaus; C. Fotopo 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 236 KB

18 SAFETY AND EFFICACY OF LOW DOSE METRO

18 SAFETY AND EFFICACY OF LOW DOSE METRONOMIC CHEMOTHERAPY WITH CAPECITABINE IN HEAVILY PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS

✍ P. Fedele; L. Orlando; P. Schiavone; P. Rizzo; N. Calvani; A. Marino; M. D'Amico 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

The impact of pretreatment thrombocytosi

The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer

✍ Maria Lee; Sang Wun Kim; Eun Ji Nam; Ga Won Yim; Sunghoon Kim; Young Tae Kim 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 268 KB

The efficacy and safety of chemotherapy

The efficacy and safety of chemotherapy in combination with bevacizumab vs. bevacizumab alone in recurrent epithelial ovarian cancer – A multi-institutional study

✍ K. Fuh; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; K. Bevis; A. ElNaggar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB